| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.36 | 0.03 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.33 | 0.3 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.2 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.6 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.003 |